Trial Profile
A Study to Evaluate the Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer (mCRPC) after Chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Mar 2016 New trial record